Chemerin concentration in children with type 1 diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.18544/EP-01.16.02.1665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects

  2017cited by this paper
• Serum chemerin is associated with inflammatory and metabolic parameters—results of a population‐based study

  2017cited by this paper
• High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.

  2016cited by this paper
• Chemerin as an independent predictor of cardiovascular event risk

  2016cited by this paper
• Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients

  2016cited by this paper
• Independent Association of Circulating Level of Chemerin With Functional and Early Morphological Vascular Changes in Newly Diagnosed Type 2 Diabetic Patients

  2015cited by this paper
• Relationship of plasma level of chemerin and vaspin to early atherosclerotic changes and cardiac autonomic neuropathy in adolescent type 1 diabetic patients

  2015cited by this paper
• Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users

  2014cited by this paper
• Towards an integrative approach to understanding the role of chemerin in human health and disease

  2013cited by this paper
• Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes.

  2012cited by this paper
• Adipokines in inflammation and metabolic disease

  2011cited by this paper
• Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes

  2010cited by this paper
• Diabetes is a proinflammatory state: a translational perspective

  2010cited by this paper
• Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.

  2009cited by this paper
• Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells

  2009cited by this paper
• Chemerin enhances insulin signaling and potentiates insulin‐stimulated glucose uptake in 3T3‐L1 adipocytes

  2008cited by this paper
• Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study.

  2008cited by this paper
• Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism*

  2007cited by this paper
• Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

  2007cited by this paper
• Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids

  2003cited by this paper
• Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

  1999cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation

  year unknowncited by this paper

• No citing papers are available for this paper.